Mumbai: Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a ...
Syngene expands its Biologics facility in Bengaluru, adding ADC bioconjugation to accelerate development timelines and enhance services.
Syngene International plans to add bioconjugation suite for end-to-end ADC development: Our Bureau, Bengaluru Thursday, October 23, 2025, 15:15 Hrs [IST] Syngene International, a ...
Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.
Syngene International, a global CRDMO, is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru. With this new capability, Syngene will offer fully integrated, ...
3d
AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"
AGC Biologics, your friendly CDMO expert, announced an agreement to provide comprehensive development and manufacturing for Rarity PBC's gene therapy.
The EU's Annex 1 regulations promote mutual recognition of inspections and regulatory cooperation while demanding rigorous ...
AI refers to a machine-based system and ML refers to a set of techniques that can be used to train AI algorithms (2) so ML ...
EEST Orion and Abzena announce exclusive commercial license for Abzena’s antibody Orion Corporation (“Orion”) and Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates ...
Founded in 2016 by Jérémie Laurent at the Saint-Louis Hospital in Paris, a prestigious hub for leading cell therapy research, Astraveus is committed to revolutionizing the development and ...
Opportunities in viral vector manufacturing arise from rising demand for GMP-grade materials and increasing gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback